| Trial ID: | L5103 |
| Source ID: | NCT00559884
|
| Associated Drug: |
Gsk189075 (Modified And Immediate Release Formulations)
|
| Title: |
A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: GSK189075 (Modified and immediate release formulations)
|
| Outcome Measures: |
Primary: Blood samples:, collected over 24-hour period after each different form of GSK189075 given to measure amount of drug in blood|Urine:, collected over 24-hour period after dosing with each form to measure amount of urine produced & amount of sugar in urine | Secondary: Adverse events:, all visits after Day -1|blood pressure & heart rate:, screening,Day -1 - Day 1,follow-up visit|ECGs:, screening,pre-dose, Day 1|lab tests:, screening, Day -1 - Day 1,follow-up
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-11
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-04
|
| Locations: |
GSK Investigational Site, Columbus, Ohio, 43212, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00559884
|
